Noninvasive Imaging of Nanomedicines and Nanotheranostics: Principles, Progress, and Prospects

Chemical Reviews

Volumn 115, Issue 19, 2015, Pages 10907-10937

  Kunjachan, Sijumon ^a   Ehling, Josef ^a   Storm, Gert ^b,c   Kiessling, Fabian ^a   Lammers, Twan ^a,b,c  

^a RWTH AACHEN UNIVERSITY   (Germany)

^b UNIVERSITY OF TWENTE   (Netherlands)

^c UTRECHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DECISION MAKING; DRUG DELIVERY; DRUG DOSAGE; MEDICAL NANOTECHNOLOGY;

CLINICAL DECISION MAKING; DISEASE DIAGNOSIS; METASTATIC DISEASE; NANOTHERANOSTICS; NON-INVASIVE IMAGING; TARGET LOCALIZATION; TARGETED TREATMENT; TREATMENT MONITORING;

DIAGNOSIS;

ANIMAL; HUMAN; MOLECULAR IMAGING; NANOMEDICINE; THERANOSTIC NANOMEDICINE;

ANIMALS; HUMANS; MOLECULAR IMAGING; NANOMEDICINE; THERANOSTIC NANOMEDICINE;

EID: 84944239487     PISSN: 00092665     EISSN: 15206890     Source Type: Journal    
DOI: 10.1021/cr500314d     Document Type: Review

References (196)

1. European Science Foundations Forward Look Nanomedicine: An EMRC Consensus Opinion; European Science Foundation: Strasbourg, France, 2005, (www.esf.org).
2. Kataoka, K.; Harada, A.; Nagasaki, Y. Block Copolymer Micelles for Drug Delivery: Design, Characterization and Biological Significance Adv. Drug Delivery Rev. 2001, 47, 113-131
3. Panyam, J.; Labhasetwar, V. Biodegradable Nanoparticles for Drug and Gene Delivery to Cells and Tissue Adv. Drug Delivery Rev. 2003, 55, 329-347
4. Torchilin, V. P. Recent Advances with Liposomes as Pharmaceutical Carriers Nat. Rev. Drug Discovery 2005, 4, 145-160
5. Duncan, R. Polymer Conjugates as Anticancer Nanomedicines Nat. Rev. Cancer 2006, 6, 688-701
6. Langer, R. Drug Delivery and Targeting Nature 1998, 392, 5-10
7. Allen, T. M.; Cullis, P. R. Drug Delivery Systems: Entering the Mainstream Science 2004, 303, 1818-1822
8. Peer, D.; Karp, J. M.; Hong, S.; Farokhzad, O. C.; Margalit, R.; Langer, R. Nanocarriers as an Emerging Platform for Cancer Therapy Nat. Nanotechnol. 2007, 2, 751-760
9. Davis, M. E.; Chen, Z.; Shin, D. M. Nanoparticle Therapeutics: An Emerging Treatment Modality for Cancer Nat. Rev. Drug Discovery 2008, 7, 771-782
10. Liu, Y.; Miyoshi, H.; Nakamura, M. Nanomedicine for Drug Delivery and Imaging: A Promising Avenue for Cancer Therapy and Diagnosis Using Targeted Functional Nanoparticles Int. J. Cancer 2007, 120, 2527-2537
11. Lammers, T. Improving the Efficacy of Combined Modality Anticancer Therapy Using HPMA Copolymer-Based Nanomedicine Formulations Adv. Drug Delivery Rev. 2010, 62, 203-230
12. Lammers, T.; Kiessling, F.; Hennink, W. E.; Storm, G. Drug Targeting to Tumors: Principles, Pitfalls and (Pre-) Clinical Progress J. Controlled Release 2012, 161, 175-187
13. Duncan, R.; Gaspar, R. Nanomedicine(s) Under the Microscope Mol. Pharmaceutics 2011, 8, 2101-2141
14. Louie, A. Multimodality Imaging Probes: Design and Challenges Chem. Rev. 2010, 3146-3195
15. MacKay, J. A.; Li, Z. Theranostic Agents That Co-Deliver Therapeutic and Imaging Agents? Adv. Drug Delivery Rev. 2010, 62, 1003-1004
16. Sumer, B.; Gao, J. Theranostic Nanomedicine for Cancer Nanomedicine (London, U.K.) 2008, 3, 137-140
17. Janib, S. M.; Moses, A. S.; MacKay, J. A. Imaging and Drug Delivery Using Theranostic Nanoparticles Adv. Drug Delivery Rev. 2010, 62, 1052-1063
18. Lammers, T.; Subr, V.; Ulbrich, K.; Hennink, W. E.; Storm, G.; Kiessling, F. Polymeric Nanomedicines for Image-Guided Drug Delivery and Tumor-Targeted Combination Therapy Nano Today 2010, 5, 197-212
19. Xie, J.; Lee, S.; Chen, X. Nanoparticle-Based Theranostic Agents Adv. Drug Delivery Rev. 2010, 62, 1064-1079
20. Chen, X.; Gambhir, S. S.; Cheon, J. Theranostic Nanomedicine Acc. Chem. Res. 2011, 44, 841
21. Jokerst, J. V.; Gambhir, S. S. Molecular Imaging with Theranostic Nanoparticles Acc. Chem. Res. 2011, 44, 1050-1060
22. Terreno, E.; Uggeri, F.; Aime, S. Image Guided Therapy: The Advent of Theranostic Agents J. Controlled Release 2012, 161, 328-337
23. Lammers, T.; Aime, S.; Hennink, W. E.; Storm, G.; Kiessling, F. Theranostic Nanomedicine Acc. Chem. Res. 2011, 44, 1029-1038
24. Kunjachan, S.; Jayapaul, J.; Mertens, M. E.; Storm, G.; Kiessling, F.; Lammers, T. Theranostic Systems and Strategies for Monitoring Nanomedicine-Mediated Drug Targeting Curr. Pharm. Biotechnol. 2012, 13, 609-622
25. Cormode, D. P.; Skajaa, T.; Fayad, Z. A.; Mulder, W. J. M. Nanotechnology in Medical Imaging Probe Design and Applications Arterioscler., Thromb., Vasc. Biol. 2009, 29, 992-1000
26. Bar-Shalom, R.; Valdivia, A. Y.; Blaufox, M. D. PET Imaging in Oncology Semin. Nucl. Med. 2000, 30, 150-185
27. 74As]-Labeled Monoclonal Antibody Against Anionic Phospholipids. Molecular Imaging and Contrast Agent Database (MICAD); National Center for Biotechnology Information: Bethesda, MD, 2004.
28. 64Cu-Labeled Nanoparticles Comprised of Amphiphilic Block Graft Copolymers Biomacromolecules 2007, 8, 3126-3134
29. 18F Labeled Nanoparticles for in Vivo PET-CT Imaging Bioconjugate Chem. 2009, 20, 397-401
30. Herth, M. M.; Barz, M.; Jahn, M.; Zentel, R.; Rosch, F. 72/74As-Labeling of HPMA Based Polymers for Long-Term in Vivo PET Imaging Bioorg. Med. Chem. Lett. 2010, 20, 5454-5458
31. Roesch, F. Scandium-44: Benefits of a Long-Lived PET Radionuclide Available From the 44Ti/44Sc Generator System Curr. Radiopharm. 2012, 5, 187-201
32. 47Sc-Based Theragnostics: Application of 47Sc for Radionuclide Tumor Therapy in Mice J. Nucl. Med. 2014, 55, 1658-1664
33. 44Sc-Labeled Cetuximab Fab Fragment Bioconjugate Chem. 2014, 25, 2197-2204
34. Gambhir, S. S. Molecular Imaging of Cancer with Positron Emission Tomography Nat. Rev. Cancer 2002, 2, 683-693
35. Li, K. C. P.; Pandit, S. D.; Guccione, S.; Bednarski, M. D. Molecular Imaging Applications in Nanomedicine Biomed. Microdevices 2004, 6, 113-116
36. Cai, W.; Chen, X. Nanoplatforms for Targeted Molecular Imaging in Living Subjects Small 2007, 3, 1840-1854
37. Ping Li, W.; Meyer, L. A.; Capretto, D. A.; Sherman, C. D.; Anderson, C. J. Receptor-Binding, Biodistribution, and Metabolism Studies of 64 Cu-DOTA-Cetuximab, a PET-Imaging Agent for Epidermal Growth-Factor Receptor-Positive Tumors Cancer Biother. Radiopharm. 2008, 23, 158-171
38. 18F Labeled Nanoparticles for in Vivo PET-CT Imaging Bioconjugate Chem. 2009, 20, 397-401
39. 18F]FETos for in Vivo Imaging by Positron Emission Tomography Biomacromolecules 2009, 10, 1697-1703
40. Nahrendorf, M.; Keliher, E.; Panizzi, P.; Zhang, H.; Hembrador, S.; Figueiredo, J. L.; Aikawa, E.; Kelly, K.; Libby, P.; Weissleder, R. 18F-4V for PET-CT Imaging of VCAM-1 Expression in Atherosclerosis JACC Cardiovasc. Imaging 2009, 2, 1213-1222
41. 18F-PARP1 Inhibitors ChemMedChem 2011, 6, 424-427
42. 18F-SAHA) J. Med. Chem. 2011, 54, 5576-5582
43. 18F-Labeled PARP1 Inhibitor Using a Chemically Orthogonal Scavenger-Assisted High-Performance Method Angew. Chem., Int. Ed. 2011, 50, 1922-1925
44. Hendricks, J. A.; Keliher, E. J.; Wan, D.; Hilderbrand, S. A.; Weissleder, R.; Mazitschek, R. Synthesis of [18F]BODIPY: Bifunctional Reporter for Hybrid Optical/Positron Emission Tomography Imaging Angew. Chem., Int. Ed. 2012, 51, 4603-4606
45. Schieferstein, H.; Kelsch, A.; Reibel, A.; Koynov, K.; Barz, M.; Buchholz, H. G.; Bausbacher, N.; Thews, O.; Zentel, R.; Ross, T. L. 18F-Radiolabeling, Preliminary Evaluation of Folate-pHPMA Conjugates via PET Macromol. Biosci. 2014, 14, 1396-1405
46. 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Enables the Detection of Recurrent Same-Site Deep Vein Thrombosis by Illuminating Recently Formed, Neutrophil-Rich Thrombus Circulation 2014, 130, 1044-1052
47. Oh, P.; Borgstrom, P.; Witkiewicz, H.; Li, Y.; Borgstrom, B. J.; Chrastina, A.; Iwata, K.; Zinn, K. R.; Baldwin, R.; Testa, J. E.; Schnitzer, J. E. Live Dynamic Imaging of Caveolae Pumping Targeted Antibody Rapidly and Specifically Across Endothelium in the Lung Nat. Biotechnol. 2007, 25, 327-337
48. Judenhofer, M. S.; Wehrl, H. F.; Newport, D. F.; Catana, C.; Siegel, S. B.; Becker, M.; Thielscher, A.; Kneilling, M.; Lichy, M. P.; Eichner, M.; Klingel, K.; Reischl, G.; Widmaier, S.; Rocken, M.; Nutt, R. E.; Machulla, H. J.; Uludag, K.; Cherry, S. R.; Claussen, C. D.; Pichler, B. J. Simultaneous PET-MRI: A New Approach for Functional and Morphological Imaging Nat. Med. 2008, 14, 459-465
49. Nahrendorf, M.; Keliher, E.; Marinelli, B.; Waterman, P.; Feruglio, P. F.; Fexon, L.; Pivovarov, M.; Swirski, F. K.; Pittet, M. J.; Vinegoni, C.; Weissleder, R. Hybrid PET-Optical Imaging Using Targeted Probes Proc. Natl. Acad. Sci. U. S. A. 2010, 107, 7910-7915
50. Warde, N. Imaging: PET-CT Promising in Animal Studies Nat. Rev. Rheumatol. 2011, 7, 3
51. 18F] FDP) Nucl. Med. Biol. 2007, 34, 165-171
52. 64Cu for Positron Emission Tomography Imaging Bioconjugate Chem. 2011, 22, 808-818
53. Lee, H. Y.; Li, Z.; Chen, K.; Hsu, A. R.; Xu, C.; Xie, J.; Sun, S.; Chen, X. PET/MRI Dual-Modality Tumor Imaging Using Arginine-Glycine-Aspartic (RGD)-Conjugated Radiolabeled Iron Oxide Nanoparticles J. Nucl. Med. 2008, 49, 1371-1379
54. Winter, P. M.; Morawski, A. M.; Caruthers, S. D.; Fuhrhop, R. W.; Zhang, H.; Williams, T. A.; Allen, J. S.; Lacy, E. K.; Robertson, J. D.; Lanza, G. M.; Wickline, S. A. Molecular Imaging of Angiogenesis in Early-Stage Atherosclerosis with Alphav-Beta3-Integrin-Targeted Nanoparticles Circulation 2003, 108, 2270-2274
55. Flacke, S.; Fischer, S.; Scott, M. J.; Fuhrhop, R. J.; Allen, J. S.; McLean, M.; Winter, P.; Sicard, G. A.; Gaffney, P. J.; Wickline, S. A.; Lanza, G. M. Novel MRI Contrast Agent for Molecular Imaging of Fibrin Implications for Detecting Vulnerable Plaques Circulation 2001, 104, 1280-1285
56. Mulder, W. J.; Fayad, Z. A. Nanomedicine Captures Cardiovascular Disease Arterioscler., Thromb. Vasc. Biol. 2008, 28, 801-802
57. Nahrendorf, M.; Waterman, P.; Thurber, G.; Groves, K.; Rajopadhye, M.; Panizzi, P.; Marinelli, B.; Aikawa, E.; Pittet, M. J.; Swirski, F. K.; Weissleder, R. Hybrid in Vivo FMT-CT Imaging of Protease Activity in Atherosclerosis with Customized Nanosensors Arterioscler., Thromb., Vasc. Biol. 2009, 29, 1444-1451
58. Skajaa, T.; Cormode, D. P.; Falk, E.; Mulder, W. J. M.; Fisher, E. A.; Fayad, Z. A. High-Density Lipoprotein-Based Contrast Agents for Multimodal Imaging of Atherosclerosis Arterioscler., Thromb., Vasc. Biol. 2010, 30, 169-176
59. Lanza, G.; Winter, P.; Cyrus, T.; Caruthers, S.; Marsh, J.; Hughes, M.; Wickline, S. Nanomedicine Opportunities in Cardiology Ann. N. Y. Acad. Sci. 2006, 1080, 451-465
60. Lanza, G. M.; Winter, P. M.; Caruthers, S. D.; Hughes, M. S.; Cyrus, T.; Marsh, J. N.; Neubauer, A. M.; Partlow, K. C.; Wickline, S. A. Nanomedicine Opportunities for Cardiovascular Disease with Perfluorocarbon Nanoparticles Nanomedicine (London, U.K.) 2006, 1, 321-329
61. Mulder, W. J. M.; Strijkers, G. J.; van Tilborg, G. A. F.; Cormode, D. P.; Fayad, Z. A.; Nicolay, K. Nanoparticulate Assemblies of Amphiphiles and Diagnostically Active Materials for Multimodality Imaging Acc. Chem. Res. 2009, 42, 904-914
62. Huang, X.; Zhang, F.; Lee, S.; Swierczewska, M.; Kiesewetter, D. O.; Lang, L.; Zhang, G.; Zhu, L.; Gao, H.; Choi, H. S.; Niu, G.; Chen, X. Long-Term Multimodal Imaging of Tumor Draining Sentinel Lymph Nodes Using Mesoporous Silica-Based Nanoprobes Biomaterials 2012, 33, 4370-4378
63. Stockhofe, K.; Postema, J. M.; Schieferstein, H.; Ross, T. L. Radiolabeling of Nanoparticles and Polymers for PET Imaging Pharmaceuticals 2014, 7, 392-418
64. 89Zr-Labeled Cetuximab in Mice Contrast Media Mol. Imaging 2013, 8, 402-408
65. Vosjan, M. J.; Vercammen, J.; Kolkman, J. A.; Stigter-van, W. M.; Revets, H.; van Dongen, G. A. Nanobodies Targeting the Hepatocyte Growth Factor: Potential New Drugs for Molecular Cancer Therapy Mol. Cancer Ther. 2012, 11, 1017-1025
66. 89Zr-Labeled Dextran Nanoparticles Allow in Vivo Macrophage Imaging Bioconjugate Chem. 2011, 22, 2383-2389
67. 89Zr-Immuno-PET for Imaging of Long Ciculating Drugs and Disease Targets: Why, How and When to Be Applied? Q. J. Nucl. Med. Mol. Imaging 2015, 59, 18-38
68. Cohen, R.; Vugts, D. J.; Stigter-van, W. M.; Visser, G. W.; van Dongen, G. A. Inert Coupling of IRDye800CW and Zirconium-89 to Monoclonal Antibodies for Single- or Dual-Mode Fluorescence and PET Imaging Nat. Protoc. 2013, 8, 1010-1018
69. 89Zr-PET Radiochemistry in the Development and Application of Therapeutic Monoclonal Antibodies and Other Biologicals Curr. Top. Med. Chem. 2013, 13, 446-457
70. 89Zr-Nanocolloidal Albumin for Sentinel Node Identification in Oral Cancer Patients J. Nucl. Med. 2013, 54, 585-589
71. 89Zr-Nanocolloidal Albumin-Based PET/CT Lymphoscintigraphy for Sentinel Node Detection in Head and Neck Cancer: Preclinical Results J. Nucl. Med. 2011, 52, 1580-1584
72. Vugts, D. J.; van Dongen, G. A. (89)Zr-Labeled Compounds for PET Imaging Guided Personalized Therapy Drug Discovery Today: Technol. 2011, 8, e53-e61
73. Tijink, B. M.; Laeremans, T.; Budde, M.; Stigter-van, W. M.; Dreier, T.; de Haard, H. J.; Leemans, C. R.; van Dongen, G. A. Improved Tumor Targeting of Anti-Epidermal Growth Factor Receptor Nanobodies Through Albumin Binding: Taking Advantage of Modular Nanobody Technology Mol. Cancer Ther. 2008, 7, 2288-2297
74. Perk, L. R.; Visser, G. W.; Vosjan, M. J.; Stigter-van, W. M.; Tijink, B. M.; Leemans, C. R.; van Dongen, G. A. (89)Zr as a PET Surrogate Radioisotope for Scouting Biodistribution of the Therapeutic Radiometals (90)Y and (177)Lu in Tumor-Bearing Nude Mice After Coupling to the Internalizing Antibody Cetuximab J. Nucl. Med. 2005, 46, 1898-1906
75. Verel, I.; Visser, G. W.; Boellaard, R.; Boerman, O. C.; van, E. J.; Snow, G. B.; Lammertsma, A. A.; van Dongen, G. A. Quantitative 89Zr Immuno-PET for in Vivo Scouting of 90Y-Labeled Monoclonal Antibodies in Xenograft-Bearing Nude Mice J. Nucl. Med. 2003, 44, 1663-1670
76. Pérez-Medina, C.; Abdel-Atti, D.; Zhang, Y.; Longo, V. A.; Irwin, C. P.; Binderup, T.; Ruiz-Cabello, J.; Fayad, Z. A.; Lewis, J. S.; Mulder, W. J. M.; Reiner, T. A Modular Labeling Strategy for In Vivo PET and Near-Infrared Fluorescence Imaging of Nanoparticle Tumor Targeting J. Nucl. Med. 2014, 55, 1706-1711
77. Majmudar, M. D.; Yoo, J.; Keliher, E. J.; Truelove, J. J.; Iwamoto, Y.; Sena, B.; Dutta, P.; Borodovsky, A.; Fitzgerald, K.; Carli, M. F. D.; Libby, P.; Anderson, D. G.; Swirski, F. K.; Weissleder, R.; Nahrendorf, M. Polymeric Nanoparticle PET/MR Imaging Allows Macrophage Detection in Atherosclerotic Plaques Circ. Res. 2013, 122, 755-761
78. Head, H. W.; Dodd, G. D.; Bao, A.; Soundararajan, A.; Garcia-Rojas, X.; Prihoda, T. J.; McManus, L. M.; Goins, B. A.; Santoyo, C. A.; Phillips, W. T. Combination Radiofrequency Ablation and Intravenous Radiolabeled Liposomal Doxorubicin: Imaging and Quantification of Increased Drug Delivery to Tumors Radiology 2010, 255, 405
79. Chrastina, A.; Massey, K. A.; Schnitzer, J. E. Overcoming in Vivo Barriers to Targeted Nanodelivery Wiley Interdiscip.Rev.: Nanomed. Nanobiotechnol. 2011, 3, 421-437
80. Zhang, R.; Xiong, C.; Huang, M.; Zhou, M.; Huang, Q.; Wen, X.; Liang, D.; Li, C. Peptide-Conjugated Polymeric Micellar Nanoparticles for Dual SPECT and Optical Imaging of EphB4 Receptors in Prostate Cancer Xenografts Biomaterials 2011, 32, 5872-5879
81. de Vries, A.; Custers, E.; Lub, J.; van den Bosch, S.; Nicolay, K.; Grull, H. Block-Copolymer-Stabilized Iodinated Emulsions for Use as CT Contrast Agents Biomaterials 2010, 31, 6537-6544
82. Zheng, J.; Jaffray, D.; Allen, C. Quantitative CT Imaging of the Spatial and Temporal Distribution of Liposomes in a Rabbit Tumor Model Mol. Pharmaceutics 2009, 6, 571-580
83. Dunne, M.; Zheng, J.; Rosenblat, J.; Jaffray, D. A.; Allen, C. APN/CD13-Targeting as a Strategy to Alter the Tumor Accumulation of Liposomes J. Controlled Release 2011, 154, 298-305
84. Mulder, W. J.; McMahon, M. T.; Nicolay, K. The Evolution of MRI Probes: From the Initial Development to State-of-the-Art Applications NMR Biomed. 2013, 26, 725-727
85. Langereis, S.; Geelen, T.; Grull, H.; Strijkers, G. J.; Nicolay, K. Paramagnetic Liposomes for Molecular MRI and MRI-Guided Drug Delivery NMR Biomed. 2013, 26, 728-744
86. Kluza, E.; Strijkers, G. J.; Nicolay, K. Multifunctional Magnetic Resonance Imaging Probes Recent Results Cancer Res. 2013, 187, 151-190
87. Caravan, P.; Ellison, J. J.; McMurry, T. J.; Lauffer, R. B. Gadolinium(III) Chelates as MRI Contrast Agents: Structure, Dynamics, and Applications Chem. Rev. 1999, 8, 2293-2352
88. Mulder, W. J. M.; Strijkers, G. J.; van Tilborg, G. A. F.; Griffioen, A. W.; Nicolay, K. Lipid-Based Nanoparticles for Contrast-Enhanced MRI and Molecular Imaging NMR Biomed. 2006, 19, 142-164
89. Mulder, W. J.; Strijkers, G. J.; van Tilborg, G. A.; Cormode, D. P.; Fayad, Z. A.; Nicolay, K. Nanoparticulate Assemblies of Amphiphiles and Diagnostically Active Materials for Multimodality Imaging Acc. Chem. Res. 2009, 42, 904-914
90. Mulder, W. J.; Strijkers, G. J.; Vucic, E.; Cormode, D. P.; Nicolay, K.; Fayad, Z. A. Magnetic Resonance Molecular Imaging Contrast Agents and Their Application in Atherosclerosis Top. Magn. Reson. Imaging 2007, 18, 409-417
91. Mulder, W. J.; Griffioen, A. W.; Strijkers, G. J.; Cormode, D. P.; Nicolay, K.; Fayad, Z. A. Magnetic and Fluorescent Nanoparticles for Multimodality Imaging Nanomedicine (London, U. K.) 2007, 2, 307-324
92. Strijkers, G. J.; Mulder, W. J.; van Tilborg, G. A.; Nicolay, K. MRI Contrast Agents: Current Status and Future Perspectives Anticancer Agents Med. Chem. 2007, 7, 291-305
93. Terreno, E.; Castelli, D. D.; Viale, A.; Aime, S. Challenges for Molecular Magnetic Resonance Imaging Chem. Rev. 2012, 110, 3019-3042
94. Huang, R.; Han, L.; Li, J.; Liu, S.; Shao, K.; Kuang, Y.; Hu, X.; Wang, X.; Lei, H.; Jiang, C. Chlorotoxin-Modified Macromolecular Contrast Agent for MRI Tumor Diagnosis Biomaterials 2011, 32, 5177-5186
95. Sun, C.; Veiseh, O.; Gunn, J.; Fang, C.; Hansen, S.; Lee, D.; Sze, R.; Ellenbogen, R. G.; Olson, J.; Zhang, M. In Vivo MRI Detection of Gliomas by Chlorotoxin-Conjugated Superparamagnetic Nanoprobes Small 2008, 4, 372-379
96. Sun, C.; Fang, C.; Stephen, Z.; Veiseh, O.; Hansen, S.; Lee, D.; Ellenbogen, R. G.; Olson, J.; Zhang, M. Tumor-Targeted Drug Delivery and MRI Contrast Enhancement by Chlorotoxin-Conjugated Iron Oxide Nanoparticles Nanomedicine (London, U.K.) 2008, 3, 495-505
97. de Smet, M.; Heijman, E.; Langereis, S.; Hijnen, N. M.; Gruell, H. Magnetic Resonance Imaging of High Intensity Focused Ultrasound Mediated Drug Delivery From Temperature-Sensitive Liposomes: An in Vivo Proof-of-Concept Study J. Controlled Release 2011, 150, 102-110
98. Onuki, Y.; Jacobs, I.; Artemov, D.; Kato, Y. Noninvasive Visualization of in Vivo Release and Intratumoral Distribution of Surrogate MR Contrast Agent Using the Dual MR Contrast Technique Biomaterials 2010, 31, 7132-7138
99. Delli Castelli, D.; Dastru, W.; Terreno, E.; Cittadino, E.; Mainini, F.; Torres, E.; Spadaro, M.; Aime, S. In Vivo MRI Multicontrast Kinetic Analysis of the Uptake and Intracellular Trafficking of Paramagnetically Labeled Liposomes J. Controlled Release 2010, 144, 271-279
100. de Vries, I. J.; Lesterhuis, W. J.; Barentsz, J. O.; Verdijk, P.; van Krieken, J. H.; Boerman, O. C.; Oyen, W. J.; Bonenkamp, J. J.; Boezeman, J. B.; Adema, G. J.; Bulte, J. W.; Scheenen, T. W.; Punt, C. J.; Heerschap, A.; Figdor, C. G. Magnetic Resonance Tracking of Dendritic Cells in Melanoma Patients for Monitoring of Cellular Therapy Nat. Biotechnol. 2005, 23, 1407-1413
101. Ahrens, E. T.; Helfer, B. M.; OHanlon, C. F.; Schirda, C. Clinical Cell Therapy Imaging Using a Perfluorocarbon Tracer and Fluorine-19 MRI Magn. Reson. Med. 2014, 72, 1696-1701
102. Long, C. M.; van Laarhoven, H. W. M.; Bulte, J. W. M.; Levitsky, H. I. Magnetovaccination as a Novel Method To Assess and Quantify Dendritic Cell Tumor Antigen Capture and Delivery to Lymph Nodes Cancer Res. 2009, 69, 3180-3187
103. Fortin-Ripoche, J. P.; Martina, M. S.; Gazeau, F.; Menager, C.; Wilhelm, C.; Bacri, J. C.; Lesieur, S.; Clement, O. Magnetic Targeting of Magnetoliposomes to Solid Tumors with MR Imaging Monitoring in Mice: Feasibility Radiology 2006, 239, 415-424
104. Wunder, A.; Muller-Ladner, U.; Stelzer, E. H. K.; Funk, J. A.; Neumann, E.; Stehle, G.; Pap, T.; Sinn, H.; Gay, S.; Fiehn, C. Albumin-Based Drug Delivery as Novel Therapeutic Approach for Rheumatoid Arthritis J. Immunol. 2003, 170, 4793-4801
105. Licha, K.; Olbrich, C. Optical Imaging in Drug Discovery and Diagnostic Applications Adv. Drug Delivery Rev. 2005, 57, 1087-1108
106. Mountz, J. M.; Alavi, A.; Mountz, J. D. Emerging Optical and Nuclear Medicine Imaging Methods in Rheumatoid Arthritis Nat. Rev. Rheumatol. 2012, 8, 719-728
107. Ntziachristos, V.; Weissleder, R. Experimental Three-Dimensional Fluorescence Reconstruction of Diffuse Media by Use of a Normalized Born Approximation Opt. Lett. 2001, 26, 893-895
108. Kunjachan, S.; Pola, R.; Gremse, F.; Theek, B.; Ehling, J.; Moeckel, D.; Hermanns-Sachweh, B.; Pechar, M.; Ulbrich, K.; Hennink, W. E.; Storm, G.; Lederle, W.; Kiessling, F.; Lammers, T. Passive Versus Active Tumor Targeting Using RGD- and NGR-Modified Polymeric Nanomedicines Nano Lett. 2014, 14, 972-981
109. Ntziachristos, V.; Bremer, C.; Weissleder, R. Fluorescence Imaging with Near-Infrared Light: New Technological Advances That Enable in Vivo Molecular Imaging Eur. J. Radiol. 2003, 13, 195-208
110. Hyde, D.; de Kleine, R.; MacLaurin, S. A.; Miller, E.; Brooks, D. H.; Krucker, T.; Ntziachristos, V. Hybrid FMT-CT Imaging of Amyloid-Plaques in a Murine Alzheimers Disease Model NeuroImage 2009, 44, 1304-1311
111. Ntziachristos, V.; Tung, C. H.; Bremer, C.; Weissleder, R. Fluorescence Molecular Tomography Resolves Protease Activity in Vivo Nat. Med. 2002, 8, 757-760
112. Ale, A.; Ermolayev, V.; Herzog, E.; Cohrs, C.; de Angelis, M. H.; Ntziachristos, V. FMT-XCT: in Vivo Animal Studies with Hybrid Fluorescence Molecular Tomography-X-ray Computed Tomography Nat. Methods 2012, 9, 615-620
113. Kumar, S.; Richards-Kortum, R. Optical Molecular Imaging Agents for Cancer Diagnostics and Therapeutics Nanomedicine 2011, 1, 23-30
114. Dam, G. M.; Themelis, G.; Crane, L. M. A.; Harlaar, N. J.; Pleijhuis, R. G.; Kelder, W.; Sarantopoulos, A.; de Jong, J. S.; Arts, H. J. G.; Zee, A. G. J.; Bart, J.; Low, P. S.; Ntziachristos, V. Intraoperative Tumor-Specific Fluorescence Imaging in Ovarian Cancer by Folate Receptor Targeting: First In-Human Results Nat. Med. 2011, 17, 1315-1319
115. Keereweer, S.; Kerrebijn, J.; van Driel, P.; Xie, B.; Kaijzel, E.; Snoeks, T.; Que, I.; Hutteman, M.; van der Vorst, J.; Mieog, J.; Vahrmeijer, A.; van de Velde, C.; Baatenburg de Jong, R.; Lowik, C. Optical Image-Guided Surgery-"Where Do We Stand"? Mol. Imaging Biol. 2011, 13, 199-207
116. Kosaka, N.; Mitsunaga, M.; Longmire, M. R.; Choyke, P. L.; Kobayashi, H. Near Infrared Fluorescence-Guided Real-Time Endoscopic Detection of Peritoneal Ovarian Cancer Nodules Using Intravenously Injected Indocyanine Green Int. J. Cancer 2011, 129, 1671-1677
117. Chen, W.; Jarzyna, P. A.; van Tilborg, G. A. F.; Nguyen, V. A.; Cormode, D. P.; Klink, A.; Griffioen, A. W.; Randolph, G. J.; Fisher, E. A.; Mulder, W. J. M.; Fayad, Z. A. RGD Peptide Functionalized and Reconstituted High-Density Lipoprotein Nanoparticles as a Versatile and Multimodal Tumor Targeting Molecular Imaging Probe FASEB J. 2010, 24, 1689-1699
118. Kim, J. Y.; Choi, W. I.; Kim, Y. H.; Tae, G. Highly Selective in-Vivo Imaging of Tumor as an Inflammation Site by ROS Detection Using Hydrocyanine-Conjugated, Functional Nano-Carriers J. Controlled Release 2011, 156, 398-405
119. Frangioni, J. V. In Vivo Near-Infrared Fluorescence Imaging Curr. Opin. Chem. Biol. 2003, 7, 626-634
120. Kunjachan, S.; Gremse, F.; Theek, B.; Koczera, P.; Pola, R.; Pechar, M.; Etrych, T.; Ulbrich, K.; Storm, G.; Kiessling, F.; Lammers, T. Noninvasive Optical Imaging of Nanomedicine Biodistribution ACS Nano 2013, 7, 252-262
121. Veld, R. H. i.; Storm, G.; Hennink, W. E.; Kiessling, F.; Lammers, T. Macromolecular Nanotheranostics for Multimodal Anticancer Therapy Nanoscale 2011, 3, 4022-4034
122. Lammers, T.; Kuhnlein, R.; Kissel, M.; Subr, V.; Etrych, T.; Pola, R.; Pechar, M.; Ulbrich, K.; Storm, G.; Huber, P.; Peschke, P. Effect of Physicochemical Modification on the Biodistribution and Tumor Accumulation of HPMA Copolymers J. Controlled Release 2005, 110, 103-118
123. Etrych, T.; Subr, V.; Strohalm, J.; Sirova, M.; Rihova, B.; Ulbrich, K. HPMA Copolymer-Doxorubicin Conjugates: The Effects of Molecular Weight and Architecture on Biodistribution and in Vivo Activity J. Controlled Release 2012, 164, 346-354
124. Graves, E. E.; Ripoll, J.; Weissleder, R.; Ntziachristos, V. A Submillimeter Resolution Fluorescence Molecular Imaging System for Small Animal Imaging Med. Phys. 2003, 30, 901-911
125. Ntziachristos, V. Fluorescence Molecular Imaging Annu. Rev. Biomed. Eng. 2006, 8, 1-33
126. Schulz, R. B.; Ale, A.; Sarantopoulos, A.; Freyer, M.; Soehngen, E.; Zientkowska, M.; Ntziachristos, V. Hybrid System for Simultaneous Fluorescence and X-ray Computed Tomography IEEE Trans. Med. Imaging 2010, 29, 465-473
127. Panizzi, P.; Nahrendorf, M.; Figueiredo, J. L.; Panizzi, J.; Marinelli, B.; Iwamoto, Y.; Keliher, E.; Maddur, A. A.; Waterman, P.; Kroh, H. K.; Leuschner, F.; Aikawa, E.; Swirski, F. K.; Pittet, M. J.; Hackeng, T. M.; Fuentes-Prior, P.; Schneewind, O.; Bock, P. E.; Weissleder, R. In Vivo Detection of Staphylococcus aureus Endocarditis by Targeting Pathogen-Specific Prothrombin Activation Nat. Med. 2011, 17, 1142-1146
128. Lammers, T.; Peschke, P.; Kuhnlein, R.; Subr, V.; Ulbrich, K.; Debus, J.; Huber, P.; Hennink, W.; Storm, G. Effect of Radiotherapy and Hyperthermia on the Tumor Accumulation of HPMA Copolymer-Based Drug Delivery Systems J. Controlled Release 2007, 117, 333-341
129. Xu, M.; Wang, L. V. Photoacoustic Imaging in Biomedicine. Rev. Sci. Instrum. 2006, 77.
130. Razansky, D.; Ntziachristos, V. Hybrid Photoacoustic Fluorescence Molecular Tomography Using Finite-Element-Based Inversion Med. Phys. 2007, 34, 4293-4301
131. Ntziachristos, V. Going Deeper Than Microscopy: The Optical Imaging Frontier in Biology Nat. Methods 2010, 7, 603-614
132. Mallidi, S.; Larson, T.; Tam, J.; Joshi, P. P.; Karpiouk, A.; Sokolov, K.; Emelianov, S. Multiwavelength Photoacoustic Imaging and Plasmon Resonance Coupling of Gold Nanoparticles for Selective Detection of Cancer Nano Lett. 2009, 9, 2825-2831
133. Kim, C.; Cho, E. C.; Chen, J.; Song, K. H.; Au, L.; Favazza, C.; Zhang, Q.; Cobley, C. M.; Gao, F.; Xia, Y.; Wang, L. V. In Vivo Molecular Photoacoustic Tomography of Melanomas Targeted by Bioconjugated Gold Nanocages ACS Nano 2010, 4, 4559-4564
134. Manohar, S.; Ungureanu, C.; van Leeuwen, T. G. Gold Nanorods as Molecular Contrast Agents in Photoacoustic Imaging: The Promises and the Caveats Contrast Media Mol. Imaging 2011, 6, 389-400
135. Mallidi, S.; Luke, G. P.; Emelianov, S. Photoacoustic Imaging in Cancer Detection, Diagnosis, and Treatment Guidance Trends Biotechnol. 2011, 29, 213-221
136. Stritzker, J.; Kirscher, L.; Scadeng, M.; Deliolanis, N. C.; Morscher, S.; Symvoulidis, P.; Schaefer, K.; Zhang, Q.; Buckel, L.; Hess, M.; Donat, U.; Bradley, W. G.; Ntziachristos, V.; Szalay, A. A. Vaccinia Virus-Mediated Melanin Production Allows MR and Optoacoustic Deep Tissue Imaging and Laser-Induced Thermotherapy of Cancer Proc. Natl. Acad. Sci. U. S. A. 2012, 110, 3316-3320
137. Song, L.; Kim, C.; Maslov, K.; Shung, K. K.; Wang, L. V. High-Speed Dynamic 3D Photoacoustic Imaging of Sentinel Lymph Node in a Murine Model Using an Ultrasound Array Med. Phys. 2009, 36, 3724-3729
138. Song, K. H.; Kim, C.; Cobley, C. M.; Xia, Y.; Wang, L. V. Near-Infrared Gold Nanocages as a New Class of Tracers for Photoacoustic Sentinel Lymph Node Mapping on a Rat Model Nano Lett. 2009, 9, 183-188
139. Erpelding, T. N.; Kim, C.; Pramanik, M.; Jankovic, L.; Maslov, K.; Guo, Z.; Margenthaler, J. A.; Pashley, M. D.; Wang, L. V. Sentinel Lymph Nodes in the Rat: Noninvasive Photoacoustic and US Imaging with a Clinical US System Radiology 2010, 256, 102-110
140. Kim, K.; Huang, S. W.; Ashkenazi, S.; O Donnell, M.; Agarwal, A.; Kotov, N. A.; Denny, M. F.; Kaplan, M. J. Photoacoustic Imaging of Early Inflammatory Response Using Gold Nanorods Appl. Phys. Lett. 2007, 90, 223901
141. Wang, B.; Yantsen, E.; Larson, T.; Karpiouk, A. B.; Sethuraman, S.; Su, J. L.; Sokolov, K.; Emelianov, S. Y. Plasmonic Intravascular Photoacoustic Imaging for Detection of Macrophages in Atherosclerotic Plaques Nano Lett. 2008, 9, 2212-2217
142. Vonnemann, J.; Beziere, N.; Bottcher, C.; Riese, S. B.; Kuehne, C.; Dernedde, J.; Licha, K.; von, S. C.; Kosanke, Y.; Kimm, M.; Meier, R.; Ntziachristos, V.; Haag, R. Polyglycerolsulfate Functionalized Gold Nanorods as Optoacoustic Signal Nanoamplifiers for in Vivo Bioimaging of Rheumatoid Arthritis Theranostics 2014, 4, 629-641
143. Hoelen, C. G. A.; de Mul, F. F. M.; Pongers, R.; Dekker, A. Three-Dimensional Photoacoustic Imaging of Blood Vessels in Tissue Opt. Lett. 1998, 23, 648-650
144. Wang, X.; Xie, X.; Ku, G.; Wang, L. V.; Stoica, G. Noninvasive Imaging of Hemoglobin Concentration and Oxygenation in the Rat Brain Using High-Resolution Photoacoustic Tomography J. Biomed. Opt 2006, 11, 024015
145. Hu, S.; Wang, L. V. Photoacoustic Imaging and Characterization of the Microvasculature J. Biomed. Opt. 2010, 15, 1-15
146. Ntziachristos, V.; Razansky, D. Molecular Imaging by Means of Multispectral Optoacoustic Tomography (MSOT) Chem. Rev. 2010, 110, 2783-2794
147. Ho, C. J. H.; Balasundaram, G.; Driessen, W.; McLaren, R.; Wong, C. L.; Dinish, U. S.; Attia, A. B. E.; Ntziachristos, V.; Olivo, M. Multifunctional Photosensitizer-Based Contrast Agents for Photoacoustic Imaging Sci. Rep. 2014, 4, 1-6
148. Beziere, N.; Lozano, N.; Nunes, A.; Salichs, J.; Queiros, D.; Kostarelos, K.; Ntziachristos, V. Dynamic Imaging of PEGylated Indocyanine Green (ICG) Liposomes within the Tumor Microenvironment Using Multi-Spectral Optoacoustic Tomography (MSOT) Biomaterials 2015, 37, 415-424
149. Kim, J. W.; Galanzha, E. I.; Shashkov, E. V.; Moon, H. M.; Zharov, V. P. Golden Carbon Nanotubes as Multimodal Photoacoustic and Photothermal High-Contrast Molecular Agents Nat. Nanotechnol. 2009, 4, 688-694
150. Wang, Y.; Xie, X.; Wang, X.; Ku, G.; Gill, K. L.; ONeal, D. P.; Stoica, G.; Wang, L. V. Photoacoustic Tomography of a Nanoshell Contrast Agent in the in Vivo Rat Brain Nano Lett. 2004, 4, 1689-1692
151. Chen, J.; Saeki, F.; Wiley, B. J.; Cang, H.; Cobb, M. J.; Li, Z. Y.; Au, L.; Zhang, H.; Kimmey, M. B.; Li; Xia, Y. Gold Nanocages: Bioconjugation and Their Potential Use as Optical Imaging Contrast Agents Nano Lett. 2005, 5, 473-477
152. Agarwal, A.; Huang, S. W.; O Donnell, M.; Day, K. C.; Day, M.; Kotov, N.; Ashkenazi, S. Targeted Gold Nanorod Contrast Agent for Prostate Cancer Detection by Photoacoustic Imaging J. Appl. Phys. 2007, 102, 064701
153. Yang, X.; Skrabalak, S. E.; Li, Z. Y.; Xia, Y.; Wang, L. V. Photoacoustic Tomography of a Rat Cerebral Cortex in Vivo with Au Nanocages as an Optical Contrast Agent Nano Lett. 2007, 7, 3798-3802
154. Skrabalak, S. E.; Chen, J.; Sun, Y.; Lu, X.; Au, L.; Cobley, C. M.; Xia, Y. Gold Nanocages: Synthesis, Properties, and Applications Acc. Chem. Res. 2008, 41, 1587-1595
155. Chen, Y. S.; Frey, W.; Kim, S.; Kruizinga, P.; Homan, K.; Emelianov, S. Silica-Coated Gold Nanorods as Photoacoustic Signal Nanoamplifiers Nano Lett. 2011, 11, 348-354
156. De La Zerda, A.; Zavaleta, C.; Keren, S.; Vaithilingam, S.; Bodapati, S.; Liu, Z.; Levi, J.; Smith, B. R.; Ma, T. J.; Oralkan, O.; Cheng, Z.; Chen, X.; Dai, H.; Khuri-Yakub, B. T.; Gambhir, S. S. Carbon Nanotubes as Photoacoustic Molecular Imaging Agents in Living Mice Nat. Nanotechnol. 2008, 3, 557-562
157. Liu, Z.; Tabakman, S.; Welsher, K.; Dai, H. Carbon Nanotubes in Biology and Medicine: In Vitro and in Vivo Detection, Imaging and Drug Delivery Nano Res. 2010, 2, 85-120
158. de la Zerda, A.; Bodapati, S.; Teed, R.; May, S. Y.; Tabakman, S. M.; Liu, Z.; Khuri-Yakub, B. T.; Chen, X.; Dai, H.; Gambhir, S. S. Family of Enhanced Photoacoustic Imaging Agents for High-Sensitivity and Multiplexing Studies in Living Mice ACS Nano 2012, 6, 4694-4701
159. Fan, Q.; Cheng, K.; Hu, X.; Ma, X.; Zhang, R.; Yang, M.; Lu, X.; Xing, L.; Huang, W.; Gambhir, S. S.; Cheng, Z. Transferring Biomarker into Molecular Probe: Melanin Nanoparticle as a Naturally Active Platform for Multimodality Imaging J. Am. Chem. Soc. 2014, 136, 15185-15194
160. Liopo, A.; Su, R.; Oraevsky, A. A. Melanin Nanoparticles as a Novel Contrast Agent for Optoacoustic Tomography Photoacoustics 2015, 3, 35-43
161. Repenko, T.; Fokong, S.; Laporte, L. D.; Go, D.; Kiessling, F.; Lammers, T.; Kuehne, A. J. C. Water-Soluble Dopamine-Based Polymers for Photoacoustic Imaging Chem. Commun. 2015, 51, 6084-6087
162. Kircher, M. F.; de la Zerda, A.; Jokerst, J. V.; Zavaleta, C. L.; Kempen, P. J.; Mittra, E.; Pitter, K.; Huang, R.; Campos, C.; Habte, F.; Sinclair, R.; Brennan, C. W.; Mellinghoff, I. K.; Holland, E. C.; Gambhir, S. S. A Brain Tumor Molecular Imaging Strategy Using a New Triple-Modality MRI-Photoacoustic-Raman Nanoparticle Nat. Med. 2012, 18, 829-834
163. Medarova, Z.; Pham, W.; Farrar, C.; Petkova, V.; Moore, A. In Vivo Imaging of SiRNA Delivery and Silencing in Tumors Nat. Med. 2007, 13, 372-377
164. Navarro, G.; Tros de Ilarduya, C. Activated and Non-Activated PAMAM Dendrimers for Gene Delivery in Vitro and in Vivo Nanomedicine 2009, 5, 287-297
165. Deckers, R.; Rome, C.; Moonen, C. T. W. The Role of Ultrasound and Magnetic Resonance in Local Drug Delivery J. Magn. Reson. Imaging 2008, 27, 400-409
166. Bohmer, M. R.; Klibanov, A. L.; Tiemann, K.; Hall, C. S.; Gruell, H.; Steinbach, O. C. Ultrasound Triggered Image-Guided Drug Delivery Eur. J. Radiol. 2009, 70, 242-253
167. Deckers, R.; Moonen, C. T. W. Ultrasound Triggered, Image Guided, Local Drug Delivery J. Controlled Release 2010, 148, 25-33
168. Hernot, S.; Klibanov, A. L. Microbubbles in Ultrasound-Triggered Drug and Gene Delivery Adv. Drug Delivery Rev. 2008, 60, 1153-1166
169. Wang, Y.; Li, X.; Zhou, Y.; Huang, P.; Xu, Y. Preparation of Nanobubbles for Ultrasound Imaging and Intracelluar Drug Delivery Int. J. Pharm. 2010, 384, 148-153
170. Kiessling, F.; Fokong, S.; Koczera, P.; Lederle, W.; Lammers, T. Ultrasound Microbubbles for Molecular Diagnosis, Therapy, and Theranostics J. Nucl. Med. 2012, 53, 345-348
171. Wheatley, M. A.; Forsberg, F.; Dube, N.; Patel, M.; Oeffinger, B. E. Surfactant-Stabilized Contrast Agent on the Nanoscale for Diagnostic Ultrasound Imaging Ultrasound Med. Biol. 2006, 32, 83-93
172. Rapoport, N.; Gao, Z.; Kennedy, A. Multifunctional Nanoparticles for Combining Ultrasonic Tumor Imaging and Targeted Chemotherapy J. Natl. Cancer Inst. 2007, 99, 1095-1106
173. Fokong, S.; Theek, B.; Wu, Z.; Koczera, P.; Appold, L.; Jorge, S.; Resch-Genger, U.; van Zandvoort, M.; Storm, G.; Kiessling, F.; Lammers, T. Image-Guided, Targeted and Triggered Drug Delivery to Tumors Using Polymer-Based Microbubbles J. Controlled Release 2012, 163, 75-81
174. Price, R. J.; Skyba, D. M.; Kaul, S.; Skalak, T. C. Delivery of Colloidal Particles and Red Blood Cells to Tissue through Microvessel Ruptures Created by Targeted Microbubble Destruction with Ultrasound Circulation 1998, 98, 1264-1267
175. Tachibana, K.; Uchida, T.; Ogawa, K.; Yamashita, N.; Tamura, K. Induction of Cell-Membrane Porosity by Ultrasound. Lancet 1999, 353.
176. Miller, D. L.; Quddus, J. Diagnostic Ultrasound Activation of Contrast Agent Gas Bodies Induces Capillary Rupture in Mice Proc. Natl. Acad. Sci. U. S. A. 2000, 97, 10179-10184
177. Ellegala, D. B.; Leong-Poi, H.; Carpenter, J. E.; Klibanov, A. L.; Kaul, S.; Shaffrey, M. E.; Sklenar, J.; Lindner, J. R. Imaging Tumor Angiogenesis with Contrast Ultrasound and Microbubbles Targeted to Alpha(v)Beta3 Circulation 2003, 108, 336-341
178. McDannold, N.; Vykhodtseva, N.; Raymond, S.; Jolesz, F. A.; Hynynen, K. MRI-Guided Targeted Blood-Brain Barrier Disruption with Focused Ultrasound: Histological Findings in Rabbits Ultrasound Med. Biol. 2005, 31, 1527-1537
179. Hauff, P.; Seemann, S.; Reszka, R.; Schultze-Mosgau, M.; Reinhardt, M.; Buzasi, T.; Plath, T.; Rosewicz, S.; Schirner, M. Evaluation of Gas-Filled Microparticles and Sonoporation as Gene Delivery System: Feasibility Study in Rodent Tumor Models Radiology 2005, 236, 572-578
180. Chen, S.; Ding, J. h.; Bekeredjian, R.; Yang, B. z.; Shohet, R. V.; Johnston, S. A.; Hohmeier, H. E.; Newgard, C. B.; Grayburn, P. A. Efficient Gene Delivery to Pancreatic Islets with Ultrasonic Microbubble Destruction Technology Proc. Natl. Acad. Sci. U. S. A. 2006, 103, 8469-8474
181. Tartis, M. S.; McCallan, J.; Lum, A. F. H.; LaBell, R.; Stieger, S. M.; Matsunaga, T. O.; Ferrara, K. W. Therapeutic Effects of Paclitaxel-Containing Ultrasound Contrast Agents Ultrasound Med. Biol. 2006, 32, 1771-1780
182. Ferrara, K.; Pollard, R.; Borden, M. Ultrasound Microbubble Contrast Agents: Fundamentals and Application to Gene and Drug Delivery Annu. Rev. Biomed. Eng. 2007, 9, 415-447
183. Merckel, L. G.; Deckers, R.; Baron, P.; Bleys, R. L. A. W.; van Diest, P. J.; Moonen, C. T. W.; Mali, W. P. T.; van den Bosch, M. A. A. J.; Bartels, L. W. The Effects of Magnetic Resonance Imaging-Guided High-Intensity Focused Ultrasound Ablation on Human Cadaver Breast Tissue Eur. J. Pharmacol. 2013, 717, 21-30
184. Cheung, T. T.; Fan, S. T.; Chan, S. C.; Chok, K. S.; Chu, F. S.; Jenkins, C. R.; Lo, R. C.; Fung, J. Y.; Chan, A. C.; Sharr, W. W.; Tsang, S. H.; Dai, W. C.; Poon, R. T.; Lo, C. M. High-Intensity Focused Ultrasound Ablation: An Effective Bridging Therapy for Hepatocellular Carcinoma Patients World J. Gastroenterol. 2013, 19, 3083-3089
185. Viallon, M.; Petrusca, L.; Auboiroux, V.; Goget, T.; Baboi, L.; Becker, C. D.; Salomir, R. Experimental Methods for Improved Spatial Control of Thermal Lesions in Magnetic Resonance-Guided Focused Ultrasound Ablation Ultrasound Med. Biol. 2013, 1-16
186. Negussie, A. H.; Yarmolenko, P. S.; Partanen, A.; Ranjan, A.; Jacobs, G.; Woods, D.; Bryant, H.; Thomasson, D.; Dewhirst, M. W.; Wood, B. J.; Dreher, M. R. Formulation and Characterisation of Magnetic Resonance Imageable Thermally Sensitive Liposomes for Use with Magnetic Resonance-Guided High Intensity Focused Ultrasound Int. J. Hyperthermia 2011, 27, 140-155
187. Ponce, A. M.; Viglianti, B. L.; Yu, D.; Yarmolenko, P. S.; Michelich, C. R.; Woo, J.; Bally, M. B.; Dewhirst, M. W. Magnetic Resonance Imaging of Temperature-Sensitive Liposome Release: Drug Dose Painting and Antitumor Effects J. Natl. Cancer Inst. 2007, 99, 53-63
188. Mo, S.; Coussios, C. C.; Seymour, L.; Carlisle, R. Ultrasound-Enhanced Drug Delivery for Cancer Expert Opin. Drug Delivery 2012, 9, 1525-1538
189. Hancock, H. A.; Smith, L. H.; Cuesta, J.; Durrani, A. K.; Angstadt, M.; Palmeri, M. L.; Kimmel, E.; Frenkel, V. Investigations into Pulsed High-Intensity Focused Ultrasound-Enhanced Delivery: Preliminary Evidence for a Novel Mechanism Ultrasound Med. Biol. 2009, 35, 1722-1736
190. Geers, B.; Lentacker, I.; Sanders, N. N.; Demeester, J.; Meairs, S.; De Smedt, S. C. Self-Assembled Liposome-Loaded Microbubbles: The Missing Link for Safe and Efficient Ultrasound Triggered Drug-Delivery J. Controlled Release 2011, 152, 249-256
191. Lammers, T.; Rizzo, L. Y.; Storm, G.; Kiessling, F. Personalized Nanomedicine Clin. Cancer Res. 2012, 18, 4889-4894
192. Harrington, K. J.; Mohammadtaghi, S.; Uster, P. S.; Glass, D.; Peters, A. M.; Vile, R. G.; Stewart, J. S. Effective Targeting of Solid Tumors in Patients with Locally Advanced Cancers by Radiolabeled Pegylated Liposomes Clin. Cancer Res. 2001, 7, 243-254
193. Seymour, L. W.; Ferry, D. R.; Anderson, D.; Hesslewood, S.; Julyan, P. J.; Poyner, R.; Doran, J.; Young, A. M.; Burtles, S.; Kerr, D. J.; Cancer Research Campaign Phase I/II Clinical Trials Committee. Hepatic Drug Targeting: Phase I Evaluation of Polymer-Bound Doxorubicin J. Clin. Oncol. 2012, 20, 1668-1676
194. Hrkach, J.; Von Hoff, D.; Mukkaram Ali, M.; Andrianova, E.; Auer, J.; Campbell, T.; De Witt, D.; Figa, M.; Figueiredo, M.; Horhota, A.; Low, S.; McDonnell, K.; Peeke, E.; Retnarajan, B.; Sabnis, A.; Schnipper, E.; Song, J. J.; Song, Y. H.; Summa, J.; Tompsett, D.; Troiano, G.; Van Geen Hoven, T.; Wright, J.; LoRusso, P.; Kantoff, P. W.; Bander, N. H.; Sweeney, C.; Farokhzad, O. C.; Langer, R.; Zale, S. Preclinical Development and Clinical Translation of a PSMA-Targeted Docetaxel Nanoparticle with a Differentiated Pharmacological Profile Sci. Transl. Med. 2012, 4, 1-11
195. Ojha, T.; Rizzo, L. Y.; Storm, G.; Kiessling, F.; Lammers, T. Image-Guided Drug Delivery: Preclinical Applications and Clinical Translation. Expert Opin. Drug Delivery 2015, 2296 - 2297.
196. Schroeder, A.; Heller, D. A.; Winslow, M. M.; Dahlman, J. E.; Pratt, G. W.; Langer, R.; Jacks, T.; Anderson, D. G. Targeting Metastatic Cancer with Nanotechnology Nat. Rev. Cancer 2011, 12, 39-50